Fig. 4From: N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelopeBlocked FGFR1 secretion facilitates its accumulation in the nuclear envelope. U2OS-R1 cells were treated with brefeldin A (secretion inhibitor), HA15 (BiP inhibitor) and 17-AAG (Hsp90 inhibitor) and FGFR1 localization was assessed with immunofluorescence (n = 3). Scale bar represents 20 µmBack to article page